Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8+ T Cell Responses
Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections.
News
Policy & Recommendations
Joint Action on REspiratory Diseases (JARED) launched
A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.
MEPs establish life-course immunisation group at the European Parliament
Launched in Brussels on 30 January to drive political momentum for broader vaccine uptake across all stages of life. The group is co-chaired by Croatian MEP Tomislav Sokol and Lithuanian MEP Vytenis Andriukaitis, a former European Commissioner for Health.
A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology
Human parainfluenza virus type 3 (HPIV-3) can cause severe respiratory tract infections. There are no convenient small-animal infection models.
An aberrant immune–epithelial progenitor niche drives viral lung sequela
The long-term physiological consequences of respiratory viral infections, particularly in the aftermath of the COVID-19 pandemic—termed post-acute sequelae of SARS-CoV-2 (PASC)—are rapidly evolving into a major public health concern.
Call to Action: Respiratory virus infections and cardiovascular disease (CVD)
Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.
What do B- and T-cells do and how do they respond?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
What is the difference between innate and adaptive immune response?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
